FeelBetter, a pioneer in Pharmaco-Clinical Intelligence technology, announced today that it has secured $5.9 million in funding. The funding round was led by Firstime Ventures and Shoni Health Ventures, with participation from Random Forest VC, The Group Ventures, and existing investor Triventures. This latest funding brings the company’s total investment to $8 million.
The Growing Problem of Suboptimal Medication Management
The use of multiple medications, known as polypharmacy, is a growing concern for senior patients with multiple chronic conditions. It leads to poor health outcomes, increased use of health services, and rising care costs. In the United States alone, suboptimal medication management results in 275,000 deaths and more than $528 billion in avoidable costs annually.
FeelBetter’s Innovative Solution
Launched in 2018, FeelBetter is tackling the challenges associated with suboptimal medication management in polypharmacy patients. The company’s Pharmaco-Clinical Intelligence combines novel pharmacology and clinical capabilities, utilizing AI and machine learning, to drive proactive, personalized medication management. This technology empowers healthcare professionals to ensure that their patients’ medication regimens are safe, effective, and appropriate.
FeelBetter’s CEO and Co-Founder, Liat Primor, emphasized the significance of their technology, saying, “FeelBetter’s purpose-built technology makes it possible to deliver a more personalized, whole-patient approach to medication management – one that goes beyond a single illness, diagnosis, or point in time, and comprehensively focuses on each individual’s care journey.”
Advantages of Pharmaco-Clinical Intelligence
FeelBetter’s Pharmaco-Clinical Intelligence synthesizes and analyzes healthcare data from multiple sources to identify patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The software also proactively suggests immediate and actionable interventions to reduce polypharmacy risks. Moreover, it aids healthcare providers in monitoring patients’ progress and measuring the impact of clinical interventions, thereby optimizing the allocation of resources to better serve patients and minimize preventable, costly use of healthcare services.
Strong Validation from Investors
FeelBetter’s unique approach has garnered support and investment from top-notch organizations. Michael Kerbis, Founding Partner of Random Forest VC, praised the algorithm behind FeelBetter’s technology: “FeelBetter’s algorithm has been trained on two decades of longitudinal clinical, pharmacy, claims, and lab data from hundreds of thousands of patients to find patterns in the complex connections and relationships between disparate data sources.”
Eran Lerer, CEO and Managing Partner of Shoni Health Ventures, recognized FeelBetter’s potential to transform the medical community’s approach to polypharmacy, stating, “FeelBetter offers a proven, end-to-end solution for the suboptimal medication management problem. It’s a groundbreaking tool that is poised to change how the medical community approaches polypharmacy, and we’re thrilled to take part in this important transformation.”
Empowering Better Healthcare
FeelBetter’s funding will support the company’s expansion, enabling them to refine their solution and empower more healthcare providers to deliver personalized, proactive care. Yoram Hordan, FeelBetter’s CTO, COO, and Co-Founder, highlighted the impact of Pharmaco-Clinical Intelligence, stating, “This unlocks unparalleled accuracy in detecting at-risk patients both individually and population-wide and enables new levels of precision in disease management and prevention.”
With its innovative health technology and strong investor backing, FeelBetter is poised to revolutionize medication management and significantly improve the lives of senior patients with multiple chronic conditions.
FeelBetter, a pioneer in Pharmaco-Clinical Intelligence technology, has raised $5.9 million in funding, bringing its total investment to $8 million. The company’s innovative solution addresses the growing public health concern of suboptimal medication management among senior patients with multiple chronic conditions. By leveraging AI and machine learning, FeelBetter’s Pharmaco-Clinical Intelligence enables proactive, personalized medication management, significantly improving health outcomes and reducing healthcare costs. Investors, including Firstime Ventures and Shoni Health Ventures, have shown strong confidence in FeelBetter’s potential to transform medication management for polypharmacy patients. The funding will support the company’s expansion and empower more healthcare providers to deliver personalized, proactive care.
Hi, I’m Oren, founder at BIGINTRO, a content strategy agency that helps B2B companies drive growth. We develop search, social, PR, and content marketing strategies tailored to business goals. I also have a dog named Milo.